IXC invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-8

  1. 1,547 Posts.
    lightbulb Created with Sketch. 512
    12/40 sites activated.

    Reassessment of trial protocol.

    No guidance on total timelines.

    November start date and an update this poor in June.

    Not just a timeline delay but a complete and utter stuff up on all fronts.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.1¢
Change
-0.006(6.19%)
Mkt cap ! $6.839M
Open High Low Value Volume
9.7¢ 9.7¢ 9.1¢ $10.1K 110.3K

Buyers (Bids)

No. Vol. Price($)
1 2 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 8998 1
View Market Depth
Last trade - 12.54pm 23/07/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.